beamsplitters Search Results


bs2 beamsplitter plate  (Thorlabs)
86
Thorlabs bs2 beamsplitter plate
Fig. 2. Optical setup for both straight- and side-view imaging probes. The calibration units are used to acquire the transmission matrix of each probe prior imaging. Following the calibration, a series of holograms is applied to a digital micromirror device, shaping the incoming laser beam. The modified wavefronts are coupled into the proximal fibre facet, which translates into focal points scanned across the distal end of the probe. Through the same fibre facet, the fluorescence signals emitted by a distal object are collected and detected by a photomultiplier tube on the proximal side, allowing reconstruction of an image. Legend: MMF, multimode fibre; DMD, digital micromirror device; ID, iris diaphragm; L, lens; HWP, half-wave plate; QWP, quarter-wave plate; BS, non-polarizing <t>beamsplitter</t> plate; PBS, polarizing beamsplitter cube; MO, microscope objective; Cam, camera; S, shutter; OI, optical isolator; M, mirror; DM, dichroic mirror; F, filter; PMT, photomultiplier tube detector. The detailed list of components can be found in the Appendix.
Bs2 Beamsplitter Plate, supplied by Thorlabs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beamsplitters/beamsplitter+plate/10__1364_slash_oe__426235-169-58-62
Average 86 stars, based on 1 article reviews
bs2 beamsplitter plate - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
bs1  (Thorlabs)
86
Thorlabs bs1
Fig. 2. Optical setup for both straight- and side-view imaging probes. The calibration units are used to acquire the transmission matrix of each probe prior imaging. Following the calibration, a series of holograms is applied to a digital micromirror device, shaping the incoming laser beam. The modified wavefronts are coupled into the proximal fibre facet, which translates into focal points scanned across the distal end of the probe. Through the same fibre facet, the fluorescence signals emitted by a distal object are collected and detected by a photomultiplier tube on the proximal side, allowing reconstruction of an image. Legend: MMF, multimode fibre; DMD, digital micromirror device; ID, iris diaphragm; L, lens; HWP, half-wave plate; QWP, quarter-wave plate; BS, non-polarizing <t>beamsplitter</t> plate; PBS, polarizing beamsplitter cube; MO, microscope objective; Cam, camera; S, shutter; OI, optical isolator; M, mirror; DM, dichroic mirror; F, filter; PMT, photomultiplier tube detector. The detailed list of components can be found in the Appendix.
Bs1, supplied by Thorlabs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beamsplitters/beamsplitter+pellicle/10__1364_slash_oe__426235-169-57-62
Average 86 stars, based on 1 article reviews
bs1 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
tunable quantum beam splitters  (Coherent Corp)
92
Coherent Corp tunable quantum beam splitters
Fig. 2. Optical setup for both straight- and side-view imaging probes. The calibration units are used to acquire the transmission matrix of each probe prior imaging. Following the calibration, a series of holograms is applied to a digital micromirror device, shaping the incoming laser beam. The modified wavefronts are coupled into the proximal fibre facet, which translates into focal points scanned across the distal end of the probe. Through the same fibre facet, the fluorescence signals emitted by a distal object are collected and detected by a photomultiplier tube on the proximal side, allowing reconstruction of an image. Legend: MMF, multimode fibre; DMD, digital micromirror device; ID, iris diaphragm; L, lens; HWP, half-wave plate; QWP, quarter-wave plate; BS, non-polarizing <t>beamsplitter</t> plate; PBS, polarizing beamsplitter cube; MO, microscope objective; Cam, camera; S, shutter; OI, optical isolator; M, mirror; DM, dichroic mirror; F, filter; PMT, photomultiplier tube detector. The detailed list of components can be found in the Appendix.
Tunable Quantum Beam Splitters, supplied by Coherent Corp, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beamsplitters/BEAMSPLITTERS/10__1103_slash_physrevx__1__011003-146-16-21
Average 92 stars, based on 1 article reviews
tunable quantum beam splitters - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier
ova igg1  (Chondrex Inc)
94
Chondrex Inc ova igg1
Alteration of the TME following LVP‐based scaffold vaccination combined with PD‐1 blockade. (a) Experimental design: Mice bearing B16‐OVA tumors were treated with the LVP‐based scaffold vaccine (Vax) on days 5 and 12 post‐tumor inoculation in combination with anti‐PD1 antibody administration ( n = 4 for the untreated group, n = 5 for the Vax+a‐PD1 group). (b) Tumor volumes were measured over time to assess the treatment efficacy. (c) Frequencies of Foxp3 + Tregs within the TME. (d, e) Quantification of tumor‐infiltrating CD4 + (d) and CD8 + (e) T cells per milligram of tumor tissue. (f) M1/M2 macrophage polarization was assessed by the ratio of CD86 to CD206 expression within the F4/80 + macrophage population. (g, h) Concentrations of anti‐OVA <t>IgG1</t> and IgG2a antibodies in the serum of the mice at the study endpoint. The data in panels (b–h) are presented as the means ± SDs. Statistical analysis was performed using an unpaired Student's t test. p < 0.05 was considered statistically significant.
Ova Igg1, supplied by Chondrex Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beamsplitters/Mouse+Anti-Ovalbumin+IgG1+Monoclonal+Antibody%2C+Clone+2322/pmc13137760-331-3-22
Average 94 stars, based on 1 article reviews
ova igg1 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
beamsplitter dualview  (Photometrics Inc)
90
Photometrics Inc beamsplitter dualview
Alteration of the TME following LVP‐based scaffold vaccination combined with PD‐1 blockade. (a) Experimental design: Mice bearing B16‐OVA tumors were treated with the LVP‐based scaffold vaccine (Vax) on days 5 and 12 post‐tumor inoculation in combination with anti‐PD1 antibody administration ( n = 4 for the untreated group, n = 5 for the Vax+a‐PD1 group). (b) Tumor volumes were measured over time to assess the treatment efficacy. (c) Frequencies of Foxp3 + Tregs within the TME. (d, e) Quantification of tumor‐infiltrating CD4 + (d) and CD8 + (e) T cells per milligram of tumor tissue. (f) M1/M2 macrophage polarization was assessed by the ratio of CD86 to CD206 expression within the F4/80 + macrophage population. (g, h) Concentrations of anti‐OVA <t>IgG1</t> and IgG2a antibodies in the serum of the mice at the study endpoint. The data in panels (b–h) are presented as the means ± SDs. Statistical analysis was performed using an unpaired Student's t test. p < 0.05 was considered statistically significant.
Beamsplitter Dualview, supplied by Photometrics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beamsplitters/beamsplitter+dualview/pmc03173513-370-16-18
Average 90 stars, based on 1 article reviews
beamsplitter dualview - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
beamsplitter matrix  (Verlag GmbH)
90
Verlag GmbH beamsplitter matrix
Alteration of the TME following LVP‐based scaffold vaccination combined with PD‐1 blockade. (a) Experimental design: Mice bearing B16‐OVA tumors were treated with the LVP‐based scaffold vaccine (Vax) on days 5 and 12 post‐tumor inoculation in combination with anti‐PD1 antibody administration ( n = 4 for the untreated group, n = 5 for the Vax+a‐PD1 group). (b) Tumor volumes were measured over time to assess the treatment efficacy. (c) Frequencies of Foxp3 + Tregs within the TME. (d, e) Quantification of tumor‐infiltrating CD4 + (d) and CD8 + (e) T cells per milligram of tumor tissue. (f) M1/M2 macrophage polarization was assessed by the ratio of CD86 to CD206 expression within the F4/80 + macrophage population. (g, h) Concentrations of anti‐OVA <t>IgG1</t> and IgG2a antibodies in the serum of the mice at the study endpoint. The data in panels (b–h) are presented as the means ± SDs. Statistical analysis was performed using an unpaired Student's t test. p < 0.05 was considered statistically significant.
Beamsplitter Matrix, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beamsplitters/beamsplitter+matrix/10__1002_slash_qute__201800011-526-15-5
Average 90 stars, based on 1 article reviews
beamsplitter matrix - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
single-edge dichroic beamsplitter  (IDEX)
90
IDEX single-edge dichroic beamsplitter
Alteration of the TME following LVP‐based scaffold vaccination combined with PD‐1 blockade. (a) Experimental design: Mice bearing B16‐OVA tumors were treated with the LVP‐based scaffold vaccine (Vax) on days 5 and 12 post‐tumor inoculation in combination with anti‐PD1 antibody administration ( n = 4 for the untreated group, n = 5 for the Vax+a‐PD1 group). (b) Tumor volumes were measured over time to assess the treatment efficacy. (c) Frequencies of Foxp3 + Tregs within the TME. (d, e) Quantification of tumor‐infiltrating CD4 + (d) and CD8 + (e) T cells per milligram of tumor tissue. (f) M1/M2 macrophage polarization was assessed by the ratio of CD86 to CD206 expression within the F4/80 + macrophage population. (g, h) Concentrations of anti‐OVA <t>IgG1</t> and IgG2a antibodies in the serum of the mice at the study endpoint. The data in panels (b–h) are presented as the means ± SDs. Statistical analysis was performed using an unpaired Student's t test. p < 0.05 was considered statistically significant.
Single Edge Dichroic Beamsplitter, supplied by IDEX, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beamsplitters/single+edge+laser+flat+dichroic+beamsplitter/pm31425794-93-11-14
Average 90 stars, based on 1 article reviews
single-edge dichroic beamsplitter - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
dispersion compensated 90:10 (r:t) beamsplitter (newport, inc.)  (MKS Instruments)
90
MKS Instruments dispersion compensated 90:10 (r:t) beamsplitter (newport, inc.)
Alteration of the TME following LVP‐based scaffold vaccination combined with PD‐1 blockade. (a) Experimental design: Mice bearing B16‐OVA tumors were treated with the LVP‐based scaffold vaccine (Vax) on days 5 and 12 post‐tumor inoculation in combination with anti‐PD1 antibody administration ( n = 4 for the untreated group, n = 5 for the Vax+a‐PD1 group). (b) Tumor volumes were measured over time to assess the treatment efficacy. (c) Frequencies of Foxp3 + Tregs within the TME. (d, e) Quantification of tumor‐infiltrating CD4 + (d) and CD8 + (e) T cells per milligram of tumor tissue. (f) M1/M2 macrophage polarization was assessed by the ratio of CD86 to CD206 expression within the F4/80 + macrophage population. (g, h) Concentrations of anti‐OVA <t>IgG1</t> and IgG2a antibodies in the serum of the mice at the study endpoint. The data in panels (b–h) are presented as the means ± SDs. Statistical analysis was performed using an unpaired Student's t test. p < 0.05 was considered statistically significant.
Dispersion Compensated 90:10 (R:T) Beamsplitter (Newport, Inc.), supplied by MKS Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beamsplitters/dispersion+compensated+90+10++r+t++beamsplitter++newport++inc++/pm28813154-30-30-31
Average 90 stars, based on 1 article reviews
dispersion compensated 90:10 (r:t) beamsplitter (newport, inc.) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
dichroic beamsplitter t505lpxr systems  (VISITRON Inc)
90
VISITRON Inc dichroic beamsplitter t505lpxr systems
Alteration of the TME following LVP‐based scaffold vaccination combined with PD‐1 blockade. (a) Experimental design: Mice bearing B16‐OVA tumors were treated with the LVP‐based scaffold vaccine (Vax) on days 5 and 12 post‐tumor inoculation in combination with anti‐PD1 antibody administration ( n = 4 for the untreated group, n = 5 for the Vax+a‐PD1 group). (b) Tumor volumes were measured over time to assess the treatment efficacy. (c) Frequencies of Foxp3 + Tregs within the TME. (d, e) Quantification of tumor‐infiltrating CD4 + (d) and CD8 + (e) T cells per milligram of tumor tissue. (f) M1/M2 macrophage polarization was assessed by the ratio of CD86 to CD206 expression within the F4/80 + macrophage population. (g, h) Concentrations of anti‐OVA <t>IgG1</t> and IgG2a antibodies in the serum of the mice at the study endpoint. The data in panels (b–h) are presented as the means ± SDs. Statistical analysis was performed using an unpaired Student's t test. p < 0.05 was considered statistically significant.
Dichroic Beamsplitter T505lpxr Systems, supplied by VISITRON Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beamsplitters/dichroic+beamsplitter+t505lpxr/pmc11379887-213-20-23
Average 90 stars, based on 1 article reviews
dichroic beamsplitter t505lpxr systems - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
dichroic beamsplitter layertec  (Layertec GmbH)
90
Layertec GmbH dichroic beamsplitter layertec
Alteration of the TME following LVP‐based scaffold vaccination combined with PD‐1 blockade. (a) Experimental design: Mice bearing B16‐OVA tumors were treated with the LVP‐based scaffold vaccine (Vax) on days 5 and 12 post‐tumor inoculation in combination with anti‐PD1 antibody administration ( n = 4 for the untreated group, n = 5 for the Vax+a‐PD1 group). (b) Tumor volumes were measured over time to assess the treatment efficacy. (c) Frequencies of Foxp3 + Tregs within the TME. (d, e) Quantification of tumor‐infiltrating CD4 + (d) and CD8 + (e) T cells per milligram of tumor tissue. (f) M1/M2 macrophage polarization was assessed by the ratio of CD86 to CD206 expression within the F4/80 + macrophage population. (g, h) Concentrations of anti‐OVA <t>IgG1</t> and IgG2a antibodies in the serum of the mice at the study endpoint. The data in panels (b–h) are presented as the means ± SDs. Statistical analysis was performed using an unpaired Student's t test. p < 0.05 was considered statistically significant.
Dichroic Beamsplitter Layertec, supplied by Layertec GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beamsplitters/dichroic+beamsplitter+layertec/10__1364_slash_oe__21__005536-399-24-26
Average 90 stars, based on 1 article reviews
dichroic beamsplitter layertec - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
dichroic beam splitter c488rdc  (AHF analysentechnik)
90
AHF analysentechnik dichroic beam splitter c488rdc
Alteration of the TME following LVP‐based scaffold vaccination combined with PD‐1 blockade. (a) Experimental design: Mice bearing B16‐OVA tumors were treated with the LVP‐based scaffold vaccine (Vax) on days 5 and 12 post‐tumor inoculation in combination with anti‐PD1 antibody administration ( n = 4 for the untreated group, n = 5 for the Vax+a‐PD1 group). (b) Tumor volumes were measured over time to assess the treatment efficacy. (c) Frequencies of Foxp3 + Tregs within the TME. (d, e) Quantification of tumor‐infiltrating CD4 + (d) and CD8 + (e) T cells per milligram of tumor tissue. (f) M1/M2 macrophage polarization was assessed by the ratio of CD86 to CD206 expression within the F4/80 + macrophage population. (g, h) Concentrations of anti‐OVA <t>IgG1</t> and IgG2a antibodies in the serum of the mice at the study endpoint. The data in panels (b–h) are presented as the means ± SDs. Statistical analysis was performed using an unpaired Student's t test. p < 0.05 was considered statistically significant.
Dichroic Beam Splitter C488rdc, supplied by AHF analysentechnik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beamsplitters/dichroic+beamsplitter/10__1074_slash_jbc__m805170200-78-11-15
Average 90 stars, based on 1 article reviews
dichroic beam splitter c488rdc - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
longpass beamsplitter  (AHF analysentechnik)
90
AHF analysentechnik longpass beamsplitter
Alteration of the TME following LVP‐based scaffold vaccination combined with PD‐1 blockade. (a) Experimental design: Mice bearing B16‐OVA tumors were treated with the LVP‐based scaffold vaccine (Vax) on days 5 and 12 post‐tumor inoculation in combination with anti‐PD1 antibody administration ( n = 4 for the untreated group, n = 5 for the Vax+a‐PD1 group). (b) Tumor volumes were measured over time to assess the treatment efficacy. (c) Frequencies of Foxp3 + Tregs within the TME. (d, e) Quantification of tumor‐infiltrating CD4 + (d) and CD8 + (e) T cells per milligram of tumor tissue. (f) M1/M2 macrophage polarization was assessed by the ratio of CD86 to CD206 expression within the F4/80 + macrophage population. (g, h) Concentrations of anti‐OVA <t>IgG1</t> and IgG2a antibodies in the serum of the mice at the study endpoint. The data in panels (b–h) are presented as the means ± SDs. Statistical analysis was performed using an unpaired Student's t test. p < 0.05 was considered statistically significant.
Longpass Beamsplitter, supplied by AHF analysentechnik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beamsplitters/longpass+beamsplitter/pmc06708366__pnas__1902443116__sapp-23-49-57
Average 90 stars, based on 1 article reviews
longpass beamsplitter - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 2. Optical setup for both straight- and side-view imaging probes. The calibration units are used to acquire the transmission matrix of each probe prior imaging. Following the calibration, a series of holograms is applied to a digital micromirror device, shaping the incoming laser beam. The modified wavefronts are coupled into the proximal fibre facet, which translates into focal points scanned across the distal end of the probe. Through the same fibre facet, the fluorescence signals emitted by a distal object are collected and detected by a photomultiplier tube on the proximal side, allowing reconstruction of an image. Legend: MMF, multimode fibre; DMD, digital micromirror device; ID, iris diaphragm; L, lens; HWP, half-wave plate; QWP, quarter-wave plate; BS, non-polarizing beamsplitter plate; PBS, polarizing beamsplitter cube; MO, microscope objective; Cam, camera; S, shutter; OI, optical isolator; M, mirror; DM, dichroic mirror; F, filter; PMT, photomultiplier tube detector. The detailed list of components can be found in the Appendix.

Journal: Optics Express

Article Title: Side-view holographic endomicroscopy via a custom-terminated multimode fibre

doi: 10.1364/oe.426235

Figure Lengend Snippet: Fig. 2. Optical setup for both straight- and side-view imaging probes. The calibration units are used to acquire the transmission matrix of each probe prior imaging. Following the calibration, a series of holograms is applied to a digital micromirror device, shaping the incoming laser beam. The modified wavefronts are coupled into the proximal fibre facet, which translates into focal points scanned across the distal end of the probe. Through the same fibre facet, the fluorescence signals emitted by a distal object are collected and detected by a photomultiplier tube on the proximal side, allowing reconstruction of an image. Legend: MMF, multimode fibre; DMD, digital micromirror device; ID, iris diaphragm; L, lens; HWP, half-wave plate; QWP, quarter-wave plate; BS, non-polarizing beamsplitter plate; PBS, polarizing beamsplitter cube; MO, microscope objective; Cam, camera; S, shutter; OI, optical isolator; M, mirror; DM, dichroic mirror; F, filter; PMT, photomultiplier tube detector. The detailed list of components can be found in the Appendix.

Article Snippet: Appendix The equipment and components used in this work are detailed as follows (refer to Fig. 2): Laser – Coherent Sapphire SF 488; OI – free-space optical isolator: Thorlabs IO-3-488-HP; HWP1, HWP2, HWP3, HWP4 – half-wave plate: Edmund multiple order M-17.5-D-.500-B-488; QWP1, QWP2, QWP3 – quarter-wave plate: Thorlabs WPMH10M-488; PBS1, PBS2 – polarizing beamsplitter cube: Thorlabs CCM1-PBS251/M; BS1, BS2 – beamsplitter plate: Thorlabs BSW10; DM – broadband dielectric mirror: Thorlabs BB1-E02, S – shutter: Thorlabs SHB05T; lens – L1, L6, L9: Thorlabs C240TMD-A, L2, L10: Thorlabs AC254-300-A-ML, L3: AC254250-A-ML, L4: Thorlabs AC254-040-A-ML, L5: Thorlabs AC254-125-A-ML, L7, L8: Thorlabs AC254-200-A-ML, L11: Thorlabs AC254-100-A-ML; DMD – digital micromirror device: Vialux V-7001; MMF – multimode fibre: CeramOptec Optran WFGe100/110/125 0.37; MO1, MO2 – microscope objective: Olympus 20X X-Apo 0.80NA/0.6WD; Cam1, Cam2 – camera: Basler acA640-750um; DM – widefield microscopy dichroic mirror: Chroma Technology T495lpxru; F – long pass filter: Thorlabs FEL0550; PMT – GaAsP amplified photomultiplier tube: Thorlabs PMT2101/M; photodiode – Thorlabs PDA36A2 (not depicted in Fig. 2; it is placed in the position of Cam1 or Cam2, for straight-view imaging and side-view imaging, respectively).

Techniques: Imaging, Transmission Assay, Modification, Fluorescence, Microscopy

Alteration of the TME following LVP‐based scaffold vaccination combined with PD‐1 blockade. (a) Experimental design: Mice bearing B16‐OVA tumors were treated with the LVP‐based scaffold vaccine (Vax) on days 5 and 12 post‐tumor inoculation in combination with anti‐PD1 antibody administration ( n = 4 for the untreated group, n = 5 for the Vax+a‐PD1 group). (b) Tumor volumes were measured over time to assess the treatment efficacy. (c) Frequencies of Foxp3 + Tregs within the TME. (d, e) Quantification of tumor‐infiltrating CD4 + (d) and CD8 + (e) T cells per milligram of tumor tissue. (f) M1/M2 macrophage polarization was assessed by the ratio of CD86 to CD206 expression within the F4/80 + macrophage population. (g, h) Concentrations of anti‐OVA IgG1 and IgG2a antibodies in the serum of the mice at the study endpoint. The data in panels (b–h) are presented as the means ± SDs. Statistical analysis was performed using an unpaired Student's t test. p < 0.05 was considered statistically significant.

Journal: Advanced Materials (Deerfield Beach, Fla.)

Article Title: Safe and Localized Lentiviral Gene Delivery via Injectable Mesoporous Scaffolds for Potent Antitumor Immunity

doi: 10.1002/adma.202516661

Figure Lengend Snippet: Alteration of the TME following LVP‐based scaffold vaccination combined with PD‐1 blockade. (a) Experimental design: Mice bearing B16‐OVA tumors were treated with the LVP‐based scaffold vaccine (Vax) on days 5 and 12 post‐tumor inoculation in combination with anti‐PD1 antibody administration ( n = 4 for the untreated group, n = 5 for the Vax+a‐PD1 group). (b) Tumor volumes were measured over time to assess the treatment efficacy. (c) Frequencies of Foxp3 + Tregs within the TME. (d, e) Quantification of tumor‐infiltrating CD4 + (d) and CD8 + (e) T cells per milligram of tumor tissue. (f) M1/M2 macrophage polarization was assessed by the ratio of CD86 to CD206 expression within the F4/80 + macrophage population. (g, h) Concentrations of anti‐OVA IgG1 and IgG2a antibodies in the serum of the mice at the study endpoint. The data in panels (b–h) are presented as the means ± SDs. Statistical analysis was performed using an unpaired Student's t test. p < 0.05 was considered statistically significant.

Article Snippet: The levels of anti‐OVA IgG1 and anti‐OVA IgG2a antibodies were quantified using mouse anti‐OVA IgG1 and mouse anti‐OVA IgG2a antibody assay kits (Chondrex, Inc., Woodinville, WA, USA; Cat# 3013 and 3015) according to the manufacturer's instructions.

Techniques: Expressing